FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

37592311000001100: Lorviqua 25mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
399921000001118 Lorviqua 25mg tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
399941000001111 Lorviqua 25mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lorviqua 25mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Is a Lorlatinib 25mg tablets true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Is a Lorviqua true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Has specific active ingredient Lorlatinib false Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) Has specific active ingredient Lorlatinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lorviqua 25mg tablets (Pfizer Ltd) 120 tablet 12 x 10 tablets Has AMP True Lorviqua 25mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Lorviqua 25mg tablets (Pfizer Ltd) 90 tablet 9 x 10 tablets Has AMP True Lorviqua 25mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start